45 results
8-K
EX-10.1
ABEO
Abeona Therapeutics Inc
3 Nov 22
Abeona Therapeutics Announces $35 Million Private Placement Financing
5:20pm
, or (III) the occurrence or worsening of any natural disaster, fire, storm, flood, disease outbreak, pandemic or epidemic.
(c) Authorization
8-K
EX-99.1
hito89b42cqvb
11 Aug 22
Abeona Therapeutics Reports Second Quarter 2022 Financial Results
7:30am
8-K
EX-99.1
9eru w11wzlsqgha8j
20 Jul 22
Other Events
7:30am
8-K
EX-99.1
negflcmbkqxk1w jgn
19 May 22
Abeona Therapeutics Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule
7:35am
8-K
EX-99.1
urodo039lfy0yrpw2q5v
17 May 22
Ultragenyx Acquires Global Rights to AAV Gene Therapy ABO-102 for Sanfilippo Syndrome Type A (MPS IIIA) from Abeona Therapeutics
8:01am
8-K
EX-99.1
678as zbt
13 May 22
Abeona Therapeutics Reports First Quarter 2022 Financial Results
7:30am
8-K
EX-99.1
xi8wuy3rt0ttyg2l
2 May 22
Abeona Therapeutics Announces Pricing of $25 Million Private Placement of Convertible Redeemable Preferred Stock
5:14pm
8-K
EX-99.1
xpibe
31 Mar 22
Abeona Therapeutics Announces Strategy Update and 2021 Financial Results
7:42am
8-K
EX-99.1
qr4bwsvscbgelurjk74r
17 Dec 21
Abeona Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
5:22pm
8-K
EX-99.1
pqe65olan87ny60 mob
16 Dec 21
Abeona Therapeutics Announces Public Offering of Common Stock and Warrants
4:42pm
8-K
EX-99.1
mthos
15 Nov 21
Abeona Therapeutics Reports Third Quarter Financial Results
4:07pm
8-K
EX-99.1
q3730j ty0ewja2eo5
21 Sep 21
Abeona Announces New Chairman, Executive Leadership Promotions and Key Talent Additions for Final Push Towards Two Biologics License
4:30pm